Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Daratumumab involved in risk of reactivation of hepatitis B virus
The Medicines and Healthcare Products Regulatory Agency (MHRA) London has announced that the product information for daratumumab will be updated to include the risk of reactivation of hepatitis B virus (HBV).
- Read more about A new pact forged to promote advanced research in human health
Bhubaneswar-based Institute of Life Sciences, an autonomous institution under the Department of Biotechnology, has signed a collaborative agreement with All India Institute of Medical Sciences, Bhubaneswar for undertaking advanced research in the area of human health & welfare. The pact aims to strengthen partnershipbetween the two institutions in research,education and outreach.
- Read more about CIMAP gets industrial agreement to commercialise herbal products
Council of Scientific and Industrial Research-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow has transferred the five technologies of herbal formulation to Nandan Impex Private Limited (NIPL), Mumbai.
- Read more about Do not prescribe Nimesulide under 12 years of age, urges PvPI
Pharmacovigilance Programme of India (PvPI) urges healthcare professionals to take require measures and do not prescribe Nimesulide for children under 12 years of age. PvPI urges to spread awareness among healthcare professionals to take all necessary precautions in order to avoid such mishappenings and to promote rational use of medicines.
- Read more about State Arogya Fair held from 13th to 15th December 2019 at Codissia Trade Fair Complex, Coimbatore
PHD Chamber in association with Ministry of AYUSH, Govt. of India and Department of AYUSH, State Govt. of Tamil Nadu inaugurated 3 day Conference cum Exhibition on 13th December 2019 at Codissia Trade Fair Complex, Coimbatore, Tamil Nadu.

Caption: L-R: Padamshree Dr. P.R. Krishna Kumar, CMD, Arya Viadya Pharmacy, Mr. Vivek Seigell, Principal Director, PHD Chamber, Dr. K. Kanakavali, Director General, Central Council for Research in Siddha, Chennai, Thiru S. Ganesh, IAS, Director, Indian Medicine and Homeopathy, Government of Tamil Nadu, Mr. E. V. Shiril, Chairman-Kerala Chapter, PHD Chamber.
- Read more about FDA approves generic Febuxostat Tablets
Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, has received FDA approval for their generic version of Febuxostat 40mg and 80mg tablets. The product is AB rated to the brand Uloric©, marketed by Takeda Pharmaceuticals America, Inc. The company has commenced shipping of the product that is available in bottles of 30 tablets. Febuxostat brand and generic sales are trending over $430MIL over the previous 12 months according to recent published sales data.
(adsbygoogle = window.adsbygoogle || []).push({});
- Read more about Janssen announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the completion of the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees, from XBiotech Inc., for $750 million. Should Janssen pursue bermekimab indications outside of dermatology, XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. Janssen Research & Development, LLC will develop bermekimab. The agreement was executed through Janssen Biotech, Inc. The transaction will be accounted for as a business combination.
- Read more about A new breakthrough in developing effective antimalarial drugs
Parasites in the genus Plasmodium, which cause malaria, are transmitted to humans through bites from infected mosquitoes. The parasites manage to acclimatize to these two completely different hosts because the plasticity of their genome enables them to adapt as necessary. Scientists at the Institut Pasteur and the CNRS decided to investigate the epigenetic mechanisms behind this plasticity, in particular DNA methylation. They identified molecules capable of inhibiting DNA methylation and effectively killing even the most resistant Plasmodium falciparum parasites. The results of their research were published on November 27, 2019 in the journal ACS Central Science.
- Read more about Possible dementia vaccine closer after mice studies
A preventive treatment for dementia may proceed to clinical trials after successful animal testing.

The US-led research is looking to develop effective immunotherapy via a new vaccine to remove 'brain plaque' and tau protein aggregates linked to Alzheimer's disease.

Recent success in bigenic mice models supports progression to human trials in years to come, the researchers say.
- Read more about Targeting cholesterol metabolism in macrophages to eliminate viral infection
Recent evidence suggests a link between cholesterol metabolism and innate immunity. Upon viral infection, macrophages show reduced cholesterol synthesis accompanied by enhanced expression of antiviral genes, including type I interferon (IFN-I).